Chaitra S. Ujjani
0000-0003-1977-1510
Publication & Citation Trends
Publications
0 total
Pirtobrutinib, a Highly Selective, Non-covalent (Reversible) BTKi in R/R Marginal Zone Lymphoma: Phase 1/2 BRUIN Study.
Cited by 0
Semantic Scholar
Real-World Evidence for Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin in Classical Hodgkin Lymphoma.
Cited by 0
Semantic Scholar
Favorable Real-World Outcomes of Lisocabtagene Maraleucel in Chronic Lymphocytic Leukemia
Cited by 0
Semantic Scholar
NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026.
Cited by 1
Semantic Scholar
Three-year follow-up analysis of first-line axicabtagene ciloleucel in high-risk large B-cell lymphoma (ZUMA-12). OA
Cited by 19
Semantic Scholar
Real-world outcomes of frontline polatuzumab-rchp and impact of frailty in older adults with diffuse large B-cell lymphoma
Cited by 1
Semantic Scholar
Real-world barriers to treatment access in T-cell lymphoma
Cited by 0
Semantic Scholar
Nivolumab following CAR-T failure in multiple myeloma and non-Hodgkin lymphoma: Results of a phase 2 study
Cited by 0
Semantic Scholar
Research Topics
Chronic Lymphocytic Leukemia Research
(160)
Lymphoma Diagnosis and Treatment
(149)
CAR-T cell therapy research
(61)
Advanced Breast Cancer Therapies
(30)
Viral-associated cancers and disorders
(19)
Affiliations
Roswell Park Comprehensive Cancer Center
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa
Seattle Cancer Care Alliance
Georgetown University
University of Washington